Sharekhan

Rossari Biotech Ltd

Mon 3/11/2025,15:58:53 NSE: ROSSARI

₹ 644.90 3.95 (0.62%)
BUY NOW Buy Rossari Biotech Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Rossari Biotech Ltd

Mon 3/11/2025,16:1:0

Rossari Biotech Ltd

Mon 3/11/2025,15:58:53 | NSE : ROSSARI

₹ 644.903.95 (0.62%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 644.00

Previous Close

₹ 640.95

Volume

17699

Mkt Cap ( Rs. Cr)

₹3571.54

High

₹ 646.45

Low

₹ 640.00

52 Week High

₹ 884.70

52 Week Low

₹ 569.00

Book Value Per Share

₹ 214.05

Dividend Yield

0.07

Face Value

₹ 2.00

What’s Your Call?

Collective community sentiment on Rossari Biotech Ltd

Your Vote -

Buy

28.44%

Hold

46.29%

Sell

25.26%

28.44%

661 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Rossari Biotech Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    27 Oct 2025, 7:37PM Intimation of Transcript of Q2 FY 26 for the Earnings Conference Call held on October 17, 2025.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    27 Oct 2025, 7:35PM Intimation of Transcript of Q2 FY 26 for the Earnings Conference Call held on October 17, 2025.

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    17 Oct 2025, 6:59PM Audio recording of Earnings Conference call for Q2 FY 26.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    17 Oct 2025, 6:52PM Audio recording of Earnings Conference call for Q2 FY 26.

  • Rossari Biotech - Copy of Newspaper Publication

    17 Oct 2025, 4:44PM Newspaper publication of extract of Consolidated Unaudited Financial Results for the quarter and half year ended September 30, 2025.

  • Rossari Biotech - Press Release

    16 Oct 2025, 4:45PM Rossari Biotech Limited has informed the Exchange regarding a Press Release dated October 15, 2025, titled ""Rossari Biotech announces Q2 FY26 results

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    16 Oct 2025, 4:45PM Rossari Biotech Limited informed the Exchange regarding Press Release dated October 15, 2025 titled \Rossari Biotech announces Q2 FY 26 Results\

  • Rossari Biotech - Investor Presentation

    16 Oct 2025, 4:37PM Rossari Biotech Limited has informed the Exchange about Investor Presentation

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Investor Presentation

    16 Oct 2025, 4:34PM Intimation of Q2 & H1 FY26 -Earnings Presentation.

  • Rossari Biotech - General Updates

    15 Oct 2025, 9:27PM Intimation under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201

    15 Oct 2025, 9:27PM Intimation under Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015

  • Rossari Biotech - Intimation Of Grant Of Options Under Rossari Employee Stock Option Plan - 2019.

    15 Oct 2025, 9:22PM Intimation of grant of 35000 options under Rossari Employee Stock Option Plan - 2019.

  • Rossari Biotech - ESOP/ESOS/ESPS

    15 Oct 2025, 9:22PM Intimation of grant of 35000 options under Rossari Employee Stock Option Plan -2019.

  • Rossari Biotech - ESOP/ESOS/ESPS

    15 Oct 2025, 9:11PM Intimation of allotment of 14,400 Equity Shares under Rossari Employee Stock Option Plan- 2019.

  • Rossari Biotech Q2 net profit up 13.97% at Rs 31.25 cr

    15 Oct 2025, 9:10PM The company reported standalone net profit of Rs 31.25 crore for the quarter ended September 30, 2025 as compared to Rs 27.42 crore in the same period

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    15 Oct 2025, 9:10PM Intimation of allotment of 14400 Equity Shares under Rossari Employee Stock Option Plan - 2019.

  • Rossari Biotech - Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30, 2

    15 Oct 2025, 9:05PM Unaudited Financial Results(Standalone & Consolidated) for the quarter and half year ended September 30, 2025

  • Rossari Biotech - Outcome of Board Meeting

    15 Oct 2025, 8:32PM Outcome of Board Meeting held on October 15, 2025.

  • Rossari Biotech - Board Meeting Outcome for Outcome Of Board Meeting Held On October 15, 2025.

    15 Oct 2025, 8:32PM Outcome of Board Meeting held on October 15, 2025.

  • Rossari Biotech has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025

    13 Oct 2025, 10:21PM As of September 2025, 68.18% is owned by Indian Promoters and 31.83% by Public. <p align=justify> Institutional holds 20.88% (Insurance Companies 4.36

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    9 Oct 2025, 7:24PM Intimation of Earning Conference Call for investor and analyst on Friday, October 17, 2025 at 03:30 P.M. (IST).

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    9 Oct 2025, 7:20PM Intimation of Earning Conference Call for investor and analyst on Friday, October 17, 2025 at 03:30 P.M. (IST).\r\n

  • Rossari Biotech - Updates

    9 Oct 2025, 7:11PM Rossari Biotech Limited has informed the Exchange regarding change in communication details of MUFG Intime India Private Limited (Registrar and Share

  • Rossari Biotech - Intimation Of Change In Communication Details Of Registrar And Share Transfer Agent

    9 Oct 2025, 7:09PM Rossari Biotech Limited has informed the Exchange regarding change in communication details of MUFG Intime India Private Limited (Registrar and Share

  • Rossari Biotech - Board Meeting Intimation for Board Meeting Intimation For Unaudited Financial Results (Standalone And Conso

    7 Oct 2025, 9:28PM Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/10/2025 ,inter alia, to consider and

  • Rossari Biotech - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    3 Oct 2025, 9:00PM Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants), Regulations, 2018 for the quarter ended September 30, 2025.

  • Rossari Biotech - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    3 Oct 2025, 9:00PM Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants), Regulations, 2018 for the quarter ended September 30, 2025.

  • Rossari Biotech - Trading Window

    26 Sep 2025, 9:41PM Rossari Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Rossari Biotech - Capacity addition

    26 Sep 2025, 8:09PM Update on Capacity Addition by the Company and at the Subsidiary.

  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201

    26 Sep 2025, 8:08PM Update on Capacity Addition by the Company and at the Subsidiary.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    16 Sep 2025, 8:13PM Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    16 Sep 2025, 8:13PM Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.

  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201

    29 Aug 2025, 5:21PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Updates

    29 Aug 2025, 5:20PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Disclosure under SEBI Takeover Regulations

    29 Aug 2025, 3:27PM ÿYash Sunil Chariÿhas submitted to the Exchange a copy of Disclosures under Regulation 10(6)-Report to stock Exchange in respect of any acquisition ma

  • Rossari Biotech - Disclosure under SEBI Takeover Regulations

    21 Aug 2025, 12:01PM Yash Sunil Chari has Submitted to the Exchange a copy of Disclosure under Regulation 10 (5) of the Securities and Exchange Board of India (Substantial

  • Rossari Biotech - Updates

    20 Aug 2025, 11:10PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201

    20 Aug 2025, 11:09PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 .

  • Rossari Biotech - Updates

    20 Aug 2025, 5:52PM Intimation of non-participation in the investors and analysts meet scheduled on Wednesday, August 20, 2025.

  • Rossari Biotech - Update On Investor Call.

    20 Aug 2025, 5:51PM Intimation of non-participation in the investors and analysts meet scheduled on Wednesday, August 20, 2025.

  • Rossari Biotech - Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 201

    18 Aug 2025, 6:58PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Agreements

    18 Aug 2025, 6:58PM Intimation under Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    11 Aug 2025, 3:33PM Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    11 Aug 2025, 3:32PM Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.\r\n

  • Rossari Biotech

    20 Oct 2022 , 10:21AM RBL has approved the incorporation of a wholly owned subsidiary in Bangladesh with an estimate aggregate Capital outlay of BDT 300 million (approximately Rs. 25 Crore). The Wholly Owned Subsidiary will enable the Company to expand the market for RBL products in Bangladesh. Positive for the stock

  • Rossari Biotech

    19 Jul 2021 , 10:22AM Rossari Biotech Limited (Rossari): The company has approved the acquisition of Tristar Intermediates Pvt. Ltd. As per the agreement, Rossari will be acquiring 100% of the equity share capital of Tristar Intermediates. 76% of the equity share capital will be acquired upon closure of the transaction, and the balance 24% over the next 3 years. The total enterprise value of the transaction is Rs. 120 crores. Rossari plans to fund the investment through cash on balance sheet and doesn’t intend to raise any debt for this acquisition. The transaction will add scale, provide cross-selling opportunities, and accelerate growth for Rossari, while significantly enhancing value creation in the longer term. The synergistic acquisition provides Rossari with enhanced portfolio of products, stronger presence in new & untapped international markets and access to newer technologies.

  • Rossari Biotech debuts at 58% premium

    23 Jul 2020 , 10:46AM Rossari Biotech lists at Rs. 670/Sh against the issue price of Rs. 425/Sh
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Rossari Biotech Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1107.318 1015.386 923.612 784.524 404.444
Liabilities 1107.318 1015.386 923.612 784.524 404.444
Equity 11.073 11.049 11.031 11.011 10.386
Gross Profit 186.235 161.254 122.648 122.793 120.855
Net Profit 114.742 99.645 71.39 79.474 79.102
Cash From Operating Activities 92.198 73.918 113.66 33.116 52.093
NPM(%) 8.01 8.28 7.32 7.4 11.45
Revenue 1431.628 1202.91 975.172 1072.844 690.414
Expenses 1245.393 1041.656 852.524 950.051 569.559
ROE(%) 9.67 8.4 6.02 6.7 6.67

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
20 Jun 2025 0.5 25 0.08 699.35
16 Aug 2024 0.5 25 0.08 780.3
24 May 2023 0.5 25 0.08 695.5
07 Jul 2022 0.5 25 0.08 888.75
08 Sep 2021 0.5 25 0.08 1282.15

Peers

Other companies within the same industry or sector that are comparable to Rossari Biotech Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sameera Agro And Infra Ltd 14.60 -0.34 6.70 765.15 20.78 0.00
Shreeoswal Seeds and Chemicals Ltd 15.09 1.28 10.20 5876.49 19.29 0.00
GRM Overseas Ltd 425.20 -1.17 41.85 3854.70 499.06 0.00
Jain Irrigation Systems Ltd 51.08 -0.78 60.09 44401.00 24.37 0.00

Company Info

The Promoters, commenced the specialty chemicals business on March 6, 2003, as a partnership firm in the name of `Rossari Labtech', having Mr. Edward Menezes and Mr. Sunil Chari as partners. Subsequently, on December 5, 2003, the name of the partnership firm was changed to `Rossari Biotech', and the business of the partnership was changed to that of manufacturing, purchase, sale, import, export and otherwise to deal in enzymes, textile auxiliaries, applications and products of biotechnology for textiles, leather, paper, construction materials, pharmaceuticals etc. Further, on January 17, 2004, RBIPL was admitted as partner in Rossari Biotech. On April 1, 2009, Ms. Anita Menezes, Ms. Usha Chari, Ms. Jyotishna Chari and late Ms. Irene Menezes were admitted as partners in Rossari Biotech and on June 15, 2009, Mr. Mikhail Menezes was admitted as a partner in Rossari Biotech.Major events and milestones :2003- The Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India2004- Established the first manufacturing facility at Silvassa2009- Conversion of partnership firm into the Company- Incorporation of the Company- Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research2010- Forayed into animal health and nutrition products2013- Forayed into HPPC products2014- The Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari Private Limited-Recipient of Best Innovator Award 2014 by BIRAC Govt.Of India2015- Lease granted by GIDC to the Company for setting up the manufacturing facility at Dahej2017- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 14001:20152018- Entered into an exclusive purchasing agreement with Hindustan Unilever Limited2019-Rossari Biotech files Rs 700-cr IPO papers with Sebi2020- Completion of the Pre-IPO Placement2021-Rossari Biotech announces full commissioning of its Greenfield manufacturing facility at Dahej, Gujarat.-Rossari Biotech Ltd was recently bestowed with the Goldern Peacock Award for Business Excellence 20212023-Bio Spectrum India Excellence Awards 2023 as the Bet Indian Industrial Enzymes Company 

The Promoters, commenced the specialty chemicals business on March 6, 2003, as a partnership firm in the name of `Rossari Labtech', having Mr. Edward Menezes and Mr. Sunil Chari as partners. Subsequently, on December 5, 2003, the name of the partnership firm was changed to `Rossari Biotech', and the business of the partnership was changed to that of manufacturing, purchase, sale, import, export and otherwise to deal in enzymes, textile auxiliaries, applications and products of biotechnology for textiles, leather, paper, construction materials, pharmaceuticals etc. Further, on January 17, 2004, RBIPL was admitted as partner in Rossari Biotech. On April 1, 2009, Ms. Anita Menezes, Ms. Usha Chari, Ms. Jyotishna Chari and late Ms. Irene Menezes were admitted as partners in Rossari Biotech and on June 15, 2009, Mr. Mikhail Menezes was admitted as a partner in Rossari Biotech.Major events and milestones :2003- The Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India2004- Established the first manufacturing facility at Silvassa2009- Conversion of partnership firm into the Company- Incorporation of the Company- Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research2010- Forayed into animal health and nutrition products2013- Forayed into HPPC products2014- The Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari Private Limited-Recipient of Best Innovator Award 2014 by BIRAC Govt.Of India2015- Lease granted by GIDC to the Company for setting up the manufacturing facility at Dahej2017- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 14001:20152018- Entered into an exclusive purchasing agreement with Hindustan Unilever Limited2019-Rossari Biotech files Rs 700-cr IPO papers with Sebi2020- Completion of the Pre-IPO Placement2021-Rossari Biotech announces full commissioning of its Greenfield manufacturing facility at Dahej, Gujarat.-Rossari Biotech Ltd was recently bestowed with the Goldern Peacock Award for Business Excellence 20212023-Bio Spectrum India Excellence Awards 2023 as the Bet Indian Industrial Enzymes Company 

Read More

Parent Organisation

Rossari Biotech Ltd.

Founded

10/08/2009

Managing Director

Mr.Sunil Chari

NSE Symbol

ROSSARIEQ

FAQ

The current price of Rossari Biotech Ltd is ₹ 644.90.

The 52-week high for Rossari Biotech Ltd is ₹ 646.45 and the 52-week low is ₹ 640.00.

The market capitalization of Rossari Biotech Ltd is currently ₹ 3571.54. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Rossari Biotech Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Rossari Biotech Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Rossari Biotech Ltd shares.

The CEO of Rossari Biotech Ltd is Mr.Sunil Chari, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT